Fake diabetes medication and equipment on the rise in Canada, experts warn
Recently, Diabetes Canada says it has received a surge in calls and emails from people with diabetes who saw and even purchased fraudulent medical products online.
The fake diabetes products often feature false endorsements, misusing logos from the Canadian government, Diabetes Canada and Obesity Canada.
'Over the last few months, Diabetes Canada has received a spike in calls and emails to our info and referral team from people with diabetes who saw or bought a fraudulent diabetes-related medical product,' Laura Syron, president and CEO of Diabetes Canada, said in an online statement on May 22.
Story continues below advertisement
'As someone who lives with Type 2 diabetes, I know how distressing it would be to buy something that claimed to help manage your blood sugar levels, only to have it turn out to be a scam.'
The organization emphasized that it doesn't endorse any medical products, and any ads claiming otherwise are completely fraudulent. These misleading claims include so-called 'GLP-1 oral drops,' fake blood glucose monitors and even full websites pretending to be connected to Diabetes Canada.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
Obesity Canada also spoke out after discovering that a company was illegally using its logo and photos of its founder, Dr. Arya Sharma, to sell a supplement falsely advertised as a GLP-1 alternative for weight loss.
5:51
Does this viral smoothie really contain the secret ingredients to weight loss?
'Let us be absolutely clear: Obesity Canada does not endorse any commercial products, supplements, or programs,' the organization said on its website.
Story continues below advertisement
'Obesity is a complex, chronic disease that deserves compassionate, evidence-based care — not quick fixes or miracle cures. Marketing tactics that exploit the hopes of people living with obesity are not only unethical — they are dangerous.'
One of the illegal products, unauthorized blood glucose-reading smartwatches, previously prompted a recall and safety alert from Health Canada in 2023.
In its warning, Health Canada cautioned that these glucose-reading smartwatches have not been evaluated for safety or effectiveness, and could pose serious health risks. The devices may provide inaccurate blood glucose readings or fail to deliver timely alerts, potentially leading to dangerous mistakes in diabetes management.
1:48
Bogus health food claims at Metro Vancouver store
Health Canada emphasized that no smartwatches capable of independently monitoring blood sugar levels have been authorized. Only approved devices listed in the Medical Devices Active Licence Listing (MDALL) should be used.
Story continues below advertisement
When it comes to these fake medical products, Diabetes Canada recommends that people with diabetes, their caregivers and parents always check in with their health-care provider before making any changes to devices, treatments or medications.
The organization also said it's been keeping Health Canada in the loop about the issue for the past few months and has filed a formal complaint about the misleading ads.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
2 hours ago
- Cision Canada
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada Français
MONTREAL, Aug. 4, 2025 /CNW/ - Pendopharm, a division of Pharmascience Inc., is pleased to announce that it has entered into an exclusive distribution agreement with Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, headquartered in Düsseldorf, Germany. Under the terms of the agreement, Pendopharm ® will be responsible for the commercialization of Buccolam ® (Midazolam Hydrochloride Oromucosal Solution) in Canada. Buccolam ® is indicated for the treatment of prolonged, acute, convulsive seizures in children. Pendopharm ® is pleased to announce that Health Canada has approved Buccolam ®. About Epilepsy Epilepsy is a chronic neurological disorder characterized by recurrent seizures of various types and severity. These seizures result from abnormal electrical activity in the brain and can be triggered by a range of factors, including structural abnormalities, brain inflammation, physical injury, trauma, infection, or unknown causes. It is estimated that the underlying cause of epilepsy remains undetermined in up to 50% of patients diagnosed with epilepsy. 1 Nearly 1 out of 100 Canadians live with epilepsy, and approximately 13% of them are children and youth. 1 Despite treatment with anti-seizure medications, some patients may experience prolonged acute convulsive seizures which require immediate intervention. Early treatment of acute seizures is critical to prevent escalation and improve patient outcomes. 2,3 Benzodiazepines, are considered first-line therapy for managing prolonged seizures. 4 Buccolam ® is an oromucosal solution of midazolam (a benzodiazepine) supplied in a ready-to-use, pre-filled syringes for buccal (absorbed in the mouth) administration. 5 "Prolonged convulsive seizures in pediatric patients can have significant short- and long-term impacts", said Dr. Aris Hadjinicolaou, Pediatric Neurologist at CHU Sainte-Justine. "Having access to a ready-to-use, on-label medication could facilitate timely intervention during seizures and may decrease the need for emergency medical services". " This partnership represents Pendopharm's commitment to bringing medicines that address unmet medical needs to Canadian patients," said Jad Isber, Vice President & General Manager of Pendopharm ®. "We look forward to working with Canadian neurologists and pediatricians to make Buccolam available to all patients who may benefit from it." Dr. Maximilian von Wülfing, Chief Operating Officer of Neuraxpharm, said: "Through its network of strategic partnerships around the world, Neuraxpharm is committed to expanding access to market-leading medicines. Our collaboration with Pendopharm further strengthens our position as a global CNS specialist enabling us to deliver an epilepsy treatment designed to reduce hospitalizations and provide support to patients and their caregivers." About Pendopharm ® Pendopharm, specialty division of Pharmascience Inc., is a leading Canadian specialty pharmaceutical company providing patients with innovative medicines that address unmet medical needs. Its areas of focus are gastroenterology, sports medicine & orthopedics, neurology and cardiology. Pendopharm ® has extensive experience and knowledge to successfully manage its growing product portfolio. For more information, please visit For media inquiries, please contact [email protected]. © 2025 Pendopharm, division of Pharmascience Inc. All rights reserved. About Pharmascience Inc. Pharmascience Inc. is one of the largest pharmaceutical manufacturers in Canada and is headquartered in Montreal, Canada. Pharmascience delivers high-quality medicines to over 50 countries worldwide. Pharmascience Inc.'s global presence and agile business development model provide healthcare communities around the world with the high-quality Canadian medicines to respond to patients' needs. About the Neuraxpharm Group Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding of the CNS market built over 40 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has c.1,000 employees and develops and commercialises CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, one in the Middle East, one in Australia, and globally via partners in more than 50 countries. Neuraxpharm is backed by funds advised by Permira. Neuraxpharm manufactures many of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. For more information, please visit .
CBC
3 hours ago
- CBC
Tick-borne diseases on rise due to warmer temperatures, experts say
With warmer weather, Health Canada is warning about the growing risk of tick-borne illnesses like Lyme disease now spreading to new regions. Dr. Christopher Labos weighs in and also talks about staying safe amid widespread air quality alerts due to wildfire smoke.
Global News
8 hours ago
- Global News
What to know about Lyme disease amid ‘steady increase' in Canada, U.S.
Cases of Lyme disease have been building steadily in Canada and the U.S. over the past few years, with the infectious tick-borne illness once again making its way into international headlines. Justin Timberlake last week became the latest celebrity to announce he has been battling the 'relentlessly debilitating' disease, which causes sometimes-severe symptoms that can persist for years. Other high-profile cases in recent years include the Canadian musicians Justin Bieber, Avril Lavigne and Shania Twain. Lyme disease is passed on to humans through the bites of infected ticks, which thrive in warmer temperatures. Climate change and shifting weather patterns have created more favourable conditions for ticks beyond just the hot summer months, and has also allowed ticks to expand their habitats across Canada, bringing them into closer contact with humans and animals. Health Canada warns that ticks can be active whenever the temperature stays above freezing and the ground isn't snow-covered, creating a year-round risk. Story continues below advertisement 'There has been a steady increase in the number of Lyme disease cases in Canada, primarily because the geographic range of ticks has changed over the last 20 years,' a Public Health Agency of Canada (PHAC) spokesperson told Global News in an email. 2:27 Lyme disease risks The latest national Lyme disease data shows there were 5,239 reported cases in Canada in 2024. However, PHAC says this preliminary count is likely an underestimation of the final total. A decade ago, there were only 522 reported cases in 2014. Similarly, the U.S. Centers for Disease Control and Prevention (CDC) says there were 89,470 Lyme disease cases in that country in 2023, the most recent year on record — a dramatic spike from 36,308 cases in 2013. PHAC says beyond shifting animal populations and climate change creating more favourable conditions for ticks, 'an increase in awareness of Lyme disease may also have resulted in more reported cases.' Story continues below advertisement What are the symptoms? Lyme disease is caused by a corkscrew-shaped bacteria called Borrelia burgdorferi and is primarily transmitted by infected black-legged deer ticks. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Symptoms include fever, headache, fatigue and a skin rash. If left untreated, the infection can spread to joints, the heart and the nervous system. Patients have sometimes reported agonizing pain that can last for years, sometimes disappearing and re-emerging. 1:56 Lyme disease rates increasing in Canada In his social media post announcing his diagnosis, Timberlake said he had experienced 'massive amount of nerve pain' as well as 'crazy fatigue or sickness' while performing on stage during his just-completed world tour. Story continues below advertisement He added that at one point he was unsure if he could continue with the tour, but chose to push through. Twain has said her bout of Lyme disease led to dysphonia, a medical condition that left her unable to sing, back in 2011 that took her a year to recover from. Lavigne, who contracted Lyme disease from a tick bite in 2014, told People magazine a year later that she was left bedridden for five months. 'I felt like I couldn't breathe, I couldn't talk, and I couldn't move,' the Canadian singer said at the time. 'I thought I was dying.' Both Lavigne and Bieber, who revealed his battle with the disease in 2020, were forced to take years away from performing and touring while they recovered. Last year, a 30-year-old Quebec woman opted for doctor-assisted death after years of battling the illness that left her bedridden, saying the intensity of the pain in her body was too much to bear. 2:16 Woman opts for assisted death after years of struggling with Lyme disease Are there treatments? Despite the growing concern about Lyme disease, current preventive measures are limited to using tick-repellent spray, using antibiotics and performing tick checks after spending time outdoors. Story continues below advertisement Health Canada says treating Lyme disease early improves the chance of recovery. However, it also warns symptoms may continue even after treatment, and that even continued antibiotic treatment 'hasn't been shown to improve symptoms or outcomes.' There's currently no Lyme disease vaccine available for humans. The last available vaccine, LYMERix, was discontinued in 2022 due to what the manufacturer called 'insufficient consumer demand.' However, there are clinical trials taking place in Europe and the U.S., according to Health Canada and the U.S. CDC. 6:07 What you need to know about of tick-borne illnesses Health authorities say the best way to prevent Lyme disease is to avoid tick bites. Beyond using tick-repellant spray, people are advised to wear closed-toe shoes, tuck their shirts and pants, and wear light-coloured, long-sleeved shirts and pants to spot ticks easily when going into outdoor areas where ticks are can be found. Story continues below advertisement Provincial and territorial health authorities have more information on where ticks are prominent. PHAC also has an online database of higher-risk areas across the country. Health Canada also has information online on how to remove ticks from the body to avoid infection.
